Artykuły udostępnione publicznie: - Robert O. Williams IIIWięcej informacji
Niedostępne w żadnym miejscu: 2
Manufacturing stable bacteriophage powders by including buffer system in formulations and using thin film freeze-drying technology
Y Zhang, M Soto, D Ghosh, RO Williams
Pharmaceutical Research 38, 1793-1804, 2021
Upoważnienia: US National Institutes of Health
Characterization of mRNA lipid nanoparticles by electron density mapping reconstruction: x-ray scattering with density from solution scattering (DENSS) algorithm
HM Dao, K AboulFotouh, AF Hussain, AE Marras, KP Johnston, Z Cui, ...
Pharmaceutical Research 41 (3), 501-512, 2024
Upoważnienia: US Department of Energy, US National Institutes of Health
Dostępne w jakimś miejscu: 18
Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation
YW Naguib, BL Rodriguez, X Li, SD Hursting, RO Williams III, Z Cui
Molecular pharmaceutics 11 (4), 1239-1249, 2014
Upoważnienia: US National Institutes of Health
Caveolin-1–derived peptide limits development of pulmonary fibrosis
AS Marudamuthu, YP Bhandary, L Fan, V Radhakrishnan, BA MacKenzie, ...
Science translational medicine 11 (522), eaat2848, 2019
Upoważnienia: US National Institutes of Health
A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution
X Li, SG Thakkar, TB Ruwona, RO Williams III, Z Cui
Journal of Controlled Release 204, 38-50, 2015
Upoważnienia: US National Institutes of Health
Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine
SG Thakkar, ZN Warnken, RF Alzhrani, SA Valdes, AM Aldayel, H Xu, ...
Journal of Controlled Release 292, 111-118, 2018
Upoważnienia: US National Institutes of Health
Just how prevalent are peptide therapeutic products? A critical review
Y Zhang, H Zhang, D Ghosh, RO Williams III
International journal of pharmaceutics 587, 119491, 2020
Upoważnienia: US National Institutes of Health
Bioavailability improvement of carbamazepine via oral administration of modified-release amorphous solid dispersions in rats
H Li, M Zhang, L Xiong, W Feng, RO Williams III
Pharmaceutics 12 (11), 1023, 2020
Upoważnienia: National Natural Science Foundation of China
The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures
SG Thakkar, TB Ruwona, RO Williams III, Z Cui
Human vaccines & immunotherapeutics 13 (4), 936-946, 2017
Upoważnienia: US National Institutes of Health
Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine
K AboulFotouh, N Uno, H Xu, C Moon, S Sahakijpijarn, DJ Christensen, ...
International Journal of Pharmaceutics 624, 122021, 2022
Upoważnienia: US National Institutes of Health
Solving the delivery problems of triclabendazole using cyclodextrins
D Real, D Leonardi, RO Williams, MA Repka, CJ Salomon
Aaps Pharmscitech 19, 2311-2321, 2018
Upoważnienia: Government of Argentina
Complex drug delivery systems: Controlling transdermal permeation rates with multiple active pharmaceutical ingredients
DA Davis, PP Martins, MS Zamloot, SA Kucera, RO Williams, HDC Smyth, ...
AAPS PharmSciTech 21, 1-11, 2020
Upoważnienia: US National Institutes of Health
Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis
S Hengsawas Surasarang, G Florova, AA Komissarov, S Shetty, S Idell, ...
Drug development and industrial pharmacy 44 (2), 184-198, 2018
Upoważnienia: US National Institutes of Health, American Heart Association
Influence of process parameters on the preparation of pharmaceutical films by electrostatic powder deposition
LK Prasad, JS LaFountaine, JM Keen, RO Williams III, JW McGinity
International Journal of Pharmaceutics 515 (1-2), 94-103, 2016
Upoważnienia: US National Science Foundation
Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection
JP Maincent, LK Najvar, WR Kirkpatrick, S Huang, TF Patterson, ...
Drug development and industrial pharmacy 43 (2), 264-274, 2017
Upoważnienia: US National Institutes of Health
Lack of durable protection against cotton smoke-induced acute lung injury in sheep by nebulized single chain urokinase plasminogen activator or tissue plasminogen activator
S Fukuda, P Enkhbaatar, C Nelson, RA Cox, MR Wolfson, TH Shaffer, ...
Clinical and Translational Medicine 7, 1-13, 2018
Upoważnienia: US National Institutes of Health
WJCO
Y Zhang, RO Williams III, HO Tucker
World 14 (11), 504-517, 2023
Upoważnienia: National Natural Science Foundation of China
Perfluorochemical‐facilitated plasminogen activator delivery to the airways: A novel treatment for inhalational smoke‐induced acute lung injury
MR Wolfson, P Enkhbaatar, S Fukuda, CL Nelson, RO Williams III, ...
Clinical and Translational Medicine 10 (1), 258-274, 2020
Upoważnienia: US National Institutes of Health
Nebulization of single-chain tissue-type and single-chain urokinase plasminogen activator for treatment of inhalational smoke-induced acute lung injury
SH Surasarang, S Sahakijpijarn, G Florova, AA Komissarov, CL Nelson, ...
Journal of drug delivery science and technology 46, 19-27, 2018
Upoważnienia: US National Institutes of Health
Manufacturing stable bacteriophage powders using thin film freeze-drying technology
Y Zhang, M Soto, D Ghosh, RO Williams III
bioRxiv, 2020.11. 27.401505, 2020
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy